You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Inhibitors of Mycobacterial Protein Tyrosine Phosphatase B (mPTPB) for therapy of
SBC: INXSOL LLC Topic: NIEHSDESCRIPTION (provided by applicant): ExposureTrack is an innovative and necessary service that will support the at-risk worker population. inXsol LLC (inXsol) proposed to prototype, demonstrate and evaluate ExposureTrack as a smart phone-based tool equipping individual response workers with a personal health monitoring and surveillance service. For this project inXsol will: 1) assemble and dem ...
SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
Alternative Pathway Inhibitors for Orphan Indication
SBC: BIOSENSING INSTRUMENT INC Topic: NIGMSDESCRIPTION (provided by applicant): We are proposing a technology to help in three key areas of proteomics including (a) recognition of protein interactions, (b) characterization of post translational modifications, and (c) quantitative measurements athigh spatial and/or temporal resolution to address the dynamics of protein interactions. Several significant types of protein interactions remain ...
SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
Continuing Development of PPCM Vaginal Contraceptive Microbicide
SBC: YASO THERAPEUTICS INCORPORATED Topic: NIAIDDESCRIPTION (provided by applicant): The goal of this project is to continue development of a novel, dual indication vaginal contraceptive anti-herpes microbicide product containing PPCM. We will conduct all tasks required to generate the Pharmacology/Toxicology and Chemistry Manufacturing and Controls (CMC) information required for IND submission, and outline the early clinical study designs with ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
HazReady-Online- Device Agnostic- Multi-player Group Simulation Phase II
SBC: INXSOL LLC Topic: NIEHSDESCRIPTION (provided by applicant): Project Summary inXsol proposes to design and demonstrate a web-based, multiplayer small group simulation to support instructor led HazMat worker health and safety training. This product is called HazReady. The use of distributed, low-cost simulation will allow individuals to attain a level of experience in the probable roles at typical incidents and work sites ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
A pocket-sized device for personal exposure level assessment
SBC: TF SENSORS, LLC Topic: NIEHSDESCRIPTION (provided by applicant): A pocket-sized device for personal exposure level assessment Abstract Detecting environmental toxicants is critical for better understanding of the relationship between chemical exposures and many diseases, and for more effective prevention of the related diseases. Due to large variations in the individuals' genetic susceptibility and environmental exposu ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
Nuclease Probe Mediated Sequencing
SBC: HIGH THROUGHPUT GENOMICS, INC. Topic: NHGRIThis Phase II proposal will complete the development of an innovative sequencing platform (NPSeq) based on feasibility demonstrated in Phase I. This platform uses a nuclease protection assay combined with universal PCR to produce targeted sequencing libraries. The lysis-only protocol means there is no need to extract RNA or DNA or to reverse transcribe RNA. Consequently, sequencing from fixed tiss ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
The Transfusion Chip: Phase II Technology Validation
SBC: GENOMICS USA, INC. Topic: NHLBIDESCRIPTION (provided by applicant): Blood-Typing is the progenitor of the entire field of personalized medicine. In the recently awarded 6-month Phase I, we proposed to take the first step in the development of an extremely-low-cost microarray test, TheTransfusion-Chip (T-Chip) which convert the historical practice of Blood-Typing by serology into a simple inexpensive DNA test. Here, in this fo ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
Development of IMNV Resistant Heritable Transgenic Litopenaeus vannamei
SBC: TRANSGENADA ENTERPRISES, INC Topic: 87Aquaculture stands as a potential solution for the long-term production of animal protein worldwide and is reported to achieve some of the highest feed-to-protein conversion ratios when compared to poultry, cattle, and pig farming. The shrimp aquaculture specifically, suffers from periodic and devastating disease outbreaks that continually limit crop yields. This effect stifles the development and ...
SBIR Phase I 2013 Department of Agriculture -
A New Approach for Resistant Starch in Wheat
SBC: Arcadia Biosciences, Inc. Topic: 85The United States is facing increasing levels of childhood obesity that have more than tripled in the past thirty years. With obesity comes a higher risk of related health issues such as diabetes. This project is focused on the development of novel wheat varieties for the production of high resistant starch foods. Resistant starch is considered a form of dietary fiber with beneficial health effect ...
SBIR Phase I 2013 Department of Agriculture -
SBIR Phase I: Autoclave Equivalent Composites Via In-Situ Pressurization
SBC: ADVANCED CERAMICS MANUFACTURING, LLC Topic: NMThis Small Business Innovation Research Phase I project seeks to develop materials and manufacturing processes that enable aerospace composite materials to be produced without an autoclave. To ensure the best material quality and reliability, aerospace composites are processed inside autoclaves that combine heat and pressure to fully bond multi-layered composites. Autoclaves that can accommodate a ...
SBIR Phase I 2013 National Science Foundation